Premium
PHARMACOKINETIC ANALYSIS AND CLINICAL RESULTS OF THE PHASE 1 DOSE ESCALATION AND EXPANSION CXD101 TRIAL IN RELAPSED, REFRACTORY LYMPHOMA
Author(s) -
Eyre T.A.,
Folkes L.,
Collins G.,
Hildyard C.,
Stratford M.,
Myers K.,
La Thangue N.,
Kerr D.,
Middleton M.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_186
Subject(s) - medicine , pharmacokinetics , follicular lymphoma , lymphoma , nausea , adverse effect , refractory (planetary science) , in vivo , pharmacology , ex vivo , oncology , gastroenterology , phases of clinical research , clinical trial , biology , microbiology and biotechnology , astrobiology